|Articles|May 17, 2020

China Upgrades Jilin Province COVID-19 Outbreak Risk From Medium to High

New cases came to the attention of public health officials within Shulan on May 7.

China’s state media outlet Xinhua reported May 17 that risk of a second wave associated with the virus in Jilin province has been upgraded from medium- to high-level as more cases of coronavirus disease 2019 (COVID-19) infection are emerging in the northeastern Jilin province.

“By Saturday, the province had reported a total of 125 locally transmitted confirmed cases, including 2 deaths and 95 who had been discharged from hospital after recovery. There are still 28 patients receiving treatment in hospital, all in the city of Jilin, and 938 close contacts of locally transmitted cases under medical observation,” authors of the report wrote.

In a press conference on the evolving situation held May 15, it was stated that new cases had come to the attention of public health officials within Shulan on May 7.

“After the occurrence of local cases in our city, the Shulan Municipal Party Committee and the Municipal Government acted swiftly, entered a state of total war, adopted the most stringent control measures, and went all out to prevent and control the epidemic,” the city’s mayor said.

Vice Premier Sun Chunlan, a member of the party Central Committee who oversaw outbreak control in Wuhan, was sent to inspect operations. According to another report, the state has quickly moved to replicate measures deployed during the lockdown of Hubei, “closing” more than 1000 residential buildings in the central city of Shulan and 1205 villages in rural areas.

In Hong Kong, many social distancing measures were adopted voluntarily. In a phone survey, investigators learned that 85% of those surveyed reported avoiding crowded places while almost all (99%) reported wearing face masks when leaving home by the third survey period. The city has seen about 1000 cases and 4 deaths from COVID-19 so far.

“By quickly implementing public health measures, Hong Kong has demonstrated that COVID-19 transmission can be effectively contained without resorting to the highly disruptive complete lockdown adopted by China, the USA, and Western European countries,” Benjamin Cowling, PhD, professor at the University of Hong Kong, said in a press release.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.